SlideShare uma empresa Scribd logo
1 de 4
Wendy Johnson
Clinical Research Associate
Education
University of North Carolina at Greensboro
Bachelors of Science
Biology
Pfeiffer University
Masters
Health Administration
Summary
• Over 4 years of experience working in a clinical laboratory and over 8 years of experience as a
medical laboratory technologist.
• Clinical Laboratory Areas include:
Oncology
Fluorescence In-Situ Hybridization (FISH) Assay to detect breast cancer
Epidermal Growth Factor Receptor Immuohistochemical (EGFR IHC) Assay to detect colon
cancer and used in clinical trial studies
Nuclear Matrix Protein 22 ELISA Assay to detect bladder cancer
Clinical Chemistry
Isoelectric Focusing (IEF) and High Performance Liquid Chromatography (HPLC) to detect
abnormal hemoglobin disorders
Electrospray Tandem Mass Spectrometry (MS/MS) to identify abnormal disorders of the
metabolism
Molecular Biology
PCR Amplification on high IRT level patients to detect if Cystic Fibrosis mutations were present
Professional Experience
DOCS Global
Clinical Research Associate
January 2016-Current
Design, plan, coordinate, and conduct all activities involved in
initiating, monitoring, and completing clinical research studies for in
vitro diagnostics.
Clinical Research Associate
January 2016-Current Agent representing Roche Diagnostics, Clinical Operations
Responsibilities:
• Performing or coordinating aspects of external clinical
studies including site selection, study initiation, site
monitoring, and study close out.
• Maintaining communication with study investigators to
ensure studies are completed in a timely fashion and
ensuring that study objectives are met.
• Interfacing with other Roche staff to support post launch
activities.
• Ensuring that studies adhere to FDA regulations, Good
Clinical Practices, IVD directives, and Roche policies and
procedures.
North Carolina State
Laboratory of Public Health
Medical Laboratory
Technologist
May 2011 to December 2015
Responsible for performing genetic disorder tests (cross-trained) in
all laboratories of Newborn Screening which include:
Hemoglobinopathies, Cystic Fibrosis, and Tandem Mass
Spectrometry.
Responsibilities:
• Interpreted, analyzed, and reported accurate test results of
patients.
• Provided customer service and educational support to
healthcare providers.
• Developed and implemented activities that were indicators
and monitors of accountability in the quality assurance
program (QA program includes test methodologies,
evaluation of patient test results, personnel competence,
communications, quality assurance records review, quality
control, proficiency testing, and complaint investigations).
Johnson_Wendy_15-Jan-2016 Page 2 of 4
• Increased quality improvement of receiving patient samples.
LabCorp, Inc.
Oncology Technologist
January 2008 to May 2011
LabCorp, Inc.
Specimen Laboratory
Accessioner
August 2007- December 2007
Performed various prognostic cancer testing such as lung, colon,
bladder, and primarily breast cancer patients.
Responsibilities:
• Evaluated and documented HER-2/neu signal intensity on
slides with an epifluorescence microscope for patient
records. These results helped pathologists determine
quickly if the patient was applicable for the Herceptin (breast
cancer) drug.
• Help initiated and performed clinical trials from global clients
using the Epidermal Growth Factor Receptor (EGFR)
Immunohistochemical (IHC) assay to detect cancer in the
lung and colon tissue.
Received, sorted, and accessioned blood, urine, and saliva
specimens for occupational testing.
Responsibilities:
• Regularly exceeded department sample processing goals by
working overtime as needed to meet deadlines.
• Updated database with patient information to expedite the
process time.
Johnson_Wendy_15-Jan-2016 Page 3 of 4
Johnson_Wendy_15-Jan-2016 Page 4 of 4

Mais conteúdo relacionado

Mais procurados

Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial
Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial
Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial Covance
 
Innovations in Phase I Patient Recruitment for Alzheimer's disease
Innovations in Phase I Patient Recruitment for Alzheimer's diseaseInnovations in Phase I Patient Recruitment for Alzheimer's disease
Innovations in Phase I Patient Recruitment for Alzheimer's diseaseCovance
 
Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015Elisa Swartz
 
Introduction to World Cancer Research Fund International’s Continuous Update ...
Introduction to World Cancer Research Fund International’s Continuous Update ...Introduction to World Cancer Research Fund International’s Continuous Update ...
Introduction to World Cancer Research Fund International’s Continuous Update ...World Cancer Research Fund International
 
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...ipposi
 
Using the PDCA model to improve cervical cancer
Using the PDCA model to improve cervical cancerUsing the PDCA model to improve cervical cancer
Using the PDCA model to improve cervical cancerDana D. Hines, PhD
 
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...Covance
 
Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14
Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14
Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14CORE Group
 
Clinical Research Conduct and Management Certificate Information Session
Clinical Research Conduct and Management Certificate Information SessionClinical Research Conduct and Management Certificate Information Session
Clinical Research Conduct and Management Certificate Information SessionSarah Benzuly-Nardinelli
 
Prospective Biobanking Poster 09MAR12
Prospective Biobanking Poster 09MAR12Prospective Biobanking Poster 09MAR12
Prospective Biobanking Poster 09MAR12Mike Messenger
 
FPS Pooled Testing Presentation 2/09/2021
FPS Pooled Testing Presentation 2/09/2021FPS Pooled Testing Presentation 2/09/2021
FPS Pooled Testing Presentation 2/09/2021Franklin Matters
 

Mais procurados (19)

Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial
Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial
Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial
 
Innovations in Phase I Patient Recruitment for Alzheimer's disease
Innovations in Phase I Patient Recruitment for Alzheimer's diseaseInnovations in Phase I Patient Recruitment for Alzheimer's disease
Innovations in Phase I Patient Recruitment for Alzheimer's disease
 
Curric. vit. cs
Curric. vit. csCurric. vit. cs
Curric. vit. cs
 
Poster Project
Poster ProjectPoster Project
Poster Project
 
Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015
 
Introduction to World Cancer Research Fund International’s Continuous Update ...
Introduction to World Cancer Research Fund International’s Continuous Update ...Introduction to World Cancer Research Fund International’s Continuous Update ...
Introduction to World Cancer Research Fund International’s Continuous Update ...
 
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
 
Pharmaceutical care and pharmacogenomics 2014
Pharmaceutical care and pharmacogenomics 2014Pharmaceutical care and pharmacogenomics 2014
Pharmaceutical care and pharmacogenomics 2014
 
Using the PDCA model to improve cervical cancer
Using the PDCA model to improve cervical cancerUsing the PDCA model to improve cervical cancer
Using the PDCA model to improve cervical cancer
 
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
 
Social Media the New Tool in Clinical Trial?
Social Media the New Tool in Clinical Trial?Social Media the New Tool in Clinical Trial?
Social Media the New Tool in Clinical Trial?
 
Introduction and Malaysia’s Experience in Phase 1 Clinical Trials
Introduction and Malaysia’s Experience in Phase 1 Clinical TrialsIntroduction and Malaysia’s Experience in Phase 1 Clinical Trials
Introduction and Malaysia’s Experience in Phase 1 Clinical Trials
 
Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14
Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14
Latest Learning and Resources for iCCM_Jennifer Winestock Luna_5.5.14
 
Clinical Research Conduct and Management Certificate Information Session
Clinical Research Conduct and Management Certificate Information SessionClinical Research Conduct and Management Certificate Information Session
Clinical Research Conduct and Management Certificate Information Session
 
The Continuous Update Project: Introduction to the Project
The Continuous Update Project: Introduction to the ProjectThe Continuous Update Project: Introduction to the Project
The Continuous Update Project: Introduction to the Project
 
resumewith CV
resumewith CVresumewith CV
resumewith CV
 
Prospective Biobanking Poster 09MAR12
Prospective Biobanking Poster 09MAR12Prospective Biobanking Poster 09MAR12
Prospective Biobanking Poster 09MAR12
 
Sop for rygb
Sop for rygbSop for rygb
Sop for rygb
 
FPS Pooled Testing Presentation 2/09/2021
FPS Pooled Testing Presentation 2/09/2021FPS Pooled Testing Presentation 2/09/2021
FPS Pooled Testing Presentation 2/09/2021
 

Semelhante a DOCS Resume_2016 (20)

NLW CV 2016
NLW CV 2016NLW CV 2016
NLW CV 2016
 
Corey M. Raines Resume
Corey M. Raines ResumeCorey M. Raines Resume
Corey M. Raines Resume
 
BIOMARKERS IN PERIODONTAL DISEASES
BIOMARKERS IN PERIODONTAL DISEASESBIOMARKERS IN PERIODONTAL DISEASES
BIOMARKERS IN PERIODONTAL DISEASES
 
M koppe dixon-cv.2016
M koppe dixon-cv.2016M koppe dixon-cv.2016
M koppe dixon-cv.2016
 
JannaBrancato_Resume
JannaBrancato_ResumeJannaBrancato_Resume
JannaBrancato_Resume
 
c v
c vc v
c v
 
13SEP16
13SEP1613SEP16
13SEP16
 
Patient Recruitment in Clinical Trials
Patient Recruitment in Clinical TrialsPatient Recruitment in Clinical Trials
Patient Recruitment in Clinical Trials
 
roughdraft Tega
roughdraft Tegaroughdraft Tega
roughdraft Tega
 
How evidence affects clinical practice in egypt
How evidence affects clinical practice in egyptHow evidence affects clinical practice in egypt
How evidence affects clinical practice in egypt
 
MNNELSON RESUME
MNNELSON RESUMEMNNELSON RESUME
MNNELSON RESUME
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
Laboratory resume-new
Laboratory resume-newLaboratory resume-new
Laboratory resume-new
 
ResumeNov2016
ResumeNov2016ResumeNov2016
ResumeNov2016
 
CV-Meital Elimelech-2015
CV-Meital Elimelech-2015CV-Meital Elimelech-2015
CV-Meital Elimelech-2015
 
Joanne anderson resume
Joanne anderson resumeJoanne anderson resume
Joanne anderson resume
 
International Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & GynecologyInternational Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & Gynecology
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09
 
Lisa_Grimm
Lisa_GrimmLisa_Grimm
Lisa_Grimm
 
JohnDiclericoJr_resume
JohnDiclericoJr_resumeJohnDiclericoJr_resume
JohnDiclericoJr_resume
 

DOCS Resume_2016

  • 1. Wendy Johnson Clinical Research Associate Education University of North Carolina at Greensboro Bachelors of Science Biology Pfeiffer University Masters Health Administration Summary • Over 4 years of experience working in a clinical laboratory and over 8 years of experience as a medical laboratory technologist. • Clinical Laboratory Areas include: Oncology Fluorescence In-Situ Hybridization (FISH) Assay to detect breast cancer Epidermal Growth Factor Receptor Immuohistochemical (EGFR IHC) Assay to detect colon cancer and used in clinical trial studies Nuclear Matrix Protein 22 ELISA Assay to detect bladder cancer Clinical Chemistry Isoelectric Focusing (IEF) and High Performance Liquid Chromatography (HPLC) to detect abnormal hemoglobin disorders Electrospray Tandem Mass Spectrometry (MS/MS) to identify abnormal disorders of the metabolism Molecular Biology PCR Amplification on high IRT level patients to detect if Cystic Fibrosis mutations were present
  • 2. Professional Experience DOCS Global Clinical Research Associate January 2016-Current Design, plan, coordinate, and conduct all activities involved in initiating, monitoring, and completing clinical research studies for in vitro diagnostics. Clinical Research Associate January 2016-Current Agent representing Roche Diagnostics, Clinical Operations Responsibilities: • Performing or coordinating aspects of external clinical studies including site selection, study initiation, site monitoring, and study close out. • Maintaining communication with study investigators to ensure studies are completed in a timely fashion and ensuring that study objectives are met. • Interfacing with other Roche staff to support post launch activities. • Ensuring that studies adhere to FDA regulations, Good Clinical Practices, IVD directives, and Roche policies and procedures. North Carolina State Laboratory of Public Health Medical Laboratory Technologist May 2011 to December 2015 Responsible for performing genetic disorder tests (cross-trained) in all laboratories of Newborn Screening which include: Hemoglobinopathies, Cystic Fibrosis, and Tandem Mass Spectrometry. Responsibilities: • Interpreted, analyzed, and reported accurate test results of patients. • Provided customer service and educational support to healthcare providers. • Developed and implemented activities that were indicators and monitors of accountability in the quality assurance program (QA program includes test methodologies, evaluation of patient test results, personnel competence, communications, quality assurance records review, quality control, proficiency testing, and complaint investigations). Johnson_Wendy_15-Jan-2016 Page 2 of 4
  • 3. • Increased quality improvement of receiving patient samples. LabCorp, Inc. Oncology Technologist January 2008 to May 2011 LabCorp, Inc. Specimen Laboratory Accessioner August 2007- December 2007 Performed various prognostic cancer testing such as lung, colon, bladder, and primarily breast cancer patients. Responsibilities: • Evaluated and documented HER-2/neu signal intensity on slides with an epifluorescence microscope for patient records. These results helped pathologists determine quickly if the patient was applicable for the Herceptin (breast cancer) drug. • Help initiated and performed clinical trials from global clients using the Epidermal Growth Factor Receptor (EGFR) Immunohistochemical (IHC) assay to detect cancer in the lung and colon tissue. Received, sorted, and accessioned blood, urine, and saliva specimens for occupational testing. Responsibilities: • Regularly exceeded department sample processing goals by working overtime as needed to meet deadlines. • Updated database with patient information to expedite the process time. Johnson_Wendy_15-Jan-2016 Page 3 of 4